Parenteral Drugs (India) Ltd. - Research Center
PARENTLD Group (Z) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 8.50 | 12.17 | 31.88 | 32.03 | 34.32 |
| Operating profit | -15.01 | -11.77 | -14.68 | -17.66 | -14.50 |
| Interest | 106.25 | 125.44 | 109.96 | 96.05 | 86.34 |
| Gross profit | -121.19 | -137.14 | -124.39 | -112.28 | -100.84 |
| EPS (Rs) | -25.61 | -40.82 | -38.26 | -49.61 | -32.23 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 0.07 | 0.06 | 0.25 | 1.44 | - |
| Stock adjustment | 0.56 | -0.62 | 1.14 | -1.11 | 1.06 |
| Raw material | 4.91 | 5.93 | 5.18 | 7.57 | 4.39 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 14.79 | 14.51 | 19.21 | 19.94 | 16.70 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.26 | 4.11 | 21.03 | 23.28 | 26.66 |
| Provisions made | - | - | - | - | - |
| Depreciation | 40.15 | 17.33 | 17.35 | 69.12 | 18.57 |
| Taxation | -32.76 | -32.76 | -27.66 | -33.49 | -23.31 |
| Net profit / loss | -76.36 | -121.71 | -114.07 | -147.90 | -96.09 |
| Extra ordinary item | 52.21 | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 29.82 | 29.82 | 29.82 | 29.82 | 29.82 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -176.70 | -96.75 | -46.07 | -55.13 | -42.24 |
| GPM (%) | -1,414.36 | -1,121.25 | -387.18 | -335.52 | - |
| NPM (%) | -891.20 | -995.08 | -355.06 | -441.99 | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis